1. Home
  2. EIG vs COLL Comparison

EIG vs COLL Comparison

Compare EIG & COLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Employers Holdings Inc

EIG

Employers Holdings Inc

HOLD

Current Price

$41.20

Market Cap

980.0M

Sector

Finance

ML Signal

HOLD

Logo Collegium Pharmaceutical Inc.

COLL

Collegium Pharmaceutical Inc.

HOLD

Current Price

$33.27

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EIG
COLL
Founded
2000
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Property-Casualty Insurers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
980.0M
1.2B
IPO Year
2006
2015

Fundamental Metrics

Financial Performance
Metric
EIG
COLL
Price
$41.20
$33.27
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
$51.17
AVG Volume (30 Days)
201.5K
540.9K
Earning Date
04-29-2026
05-07-2026
Dividend Yield
3.11%
N/A
EPS Growth
N/A
N/A
EPS
0.46
1.73
Revenue
$858,700,000.00
$780,567,000.00
Revenue This Year
N/A
$5.93
Revenue Next Year
$1.76
N/A
P/E Ratio
$89.43
$19.11
Revenue Growth
N/A
23.62
52 Week Low
$35.73
$23.23
52 Week High
$49.98
$50.79

Technical Indicators

Market Signals
Indicator
EIG
COLL
Relative Strength Index (RSI) 54.94 32.27
Support Level $40.58 $31.01
Resistance Level $42.57 $36.20
Average True Range (ATR) 0.79 1.24
MACD 0.31 0.12
Stochastic Oscillator 77.81 26.98

Price Performance

Historical Comparison
EIG
COLL

About EIG Employers Holdings Inc

Employers Holdings Inc is a provider of workers' compensation insurance and services focused on small and mid-sized businesses engaged in low-to-medium hazard industries. Its customers are employers, and the insurance premiums that those employers pay to account for company revenue. Substantially all of the remaining revenue is generated through investments. The company operates exclusively in the United States, and it generates more than half of its business in California. By industry, the company has exposure to restaurants, which account for roughly a fourth of the total premiums the company earns. It operates as a single reportable segment, Insurance Operations, through its wholly owned subsidiaries.

About COLL Collegium Pharmaceutical Inc.

Collegium Pharmaceutical Inc is a diversified biopharmaceutical company committed to improving the lives of people living with serious medical conditions. The company has developed, licensed, and acquired a portfolio of meaningfully differentiated products for the treatment of attention deficit hyperactivity disorder (ADHD) and moderate to severe pain. It commercializes its products in the United States, including Jornay PM, Belbuca, Xtampza ER, Nucynta ER, Nucynta IR (collectively, the Nucynta Products), and Symproic. The company's product portfolio includes Jornay PM, Belbuca, Xtampza ER, Nucynta IR, Nucynta ER, and Symproic.

Share on Social Networks: